CCNE1 and prostate carcinoma: Recent reports have shown that AR promotes the G1-S transition in androgen-responsive prostate cancer cells by the following means.32 AR increases cyclin D mRNA and cyclin E activity, decreases p21 expression, and promotes p27 degradation.